translatepress-multilingual domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gonaviance/public_html/wp-includes/functions.php on line 6114wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gonaviance/public_html/wp-includes/functions.php on line 6114
Un ensayo clínico global, dirigido por investigadores del Centro Oncológico Kimmel de Johns Hopkins y su Instituto de Convergencia, ha descubierto que agregar una vacuna antitumoral personalizada a la inmunoterapia estándar es seguro y aproximadamente el doble de probabilidades de reducir el cáncer que la inmunoterapia estándar sola para pacientes con Carcinoma hepatocelular, el tipo más común de cáncer de hígado.
